Needham reiterates USD 418.00 target for Stryker stock

Published on 10/16/2026 at 16:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Results are due October 29, 2026. Stryker stock costs EUR 264.80 on October 16, 2026, 1.53 percent above the Xetra close of EUR 260.80.

Analyst target and earnings date

Needham reiterated a USD 418.00 target on October 6, 2026.
Stryker reported USD 6.59 billion in second-quarter 2026 revenue, up 9.40 percent year over year.
Stryker stock traded at EUR 264.80 at 4:05 p.m. CEST at Lang & Schwarz on October 16, 2026, 1.53 percent above the Xetra close of October 15, 2026.
Stryker had a USD 113.5 billion market capitalization and a 30.84 price-to-earnings ratio as of October 16, 2026.

3D-Architekturrender eines modernen verglasten Firmengebäudes mit klarer Fassade — Architektonisches 3D-Render eines modernen Glasgebäudes repräsentiert den Unternehmenssitz von Stryker Corp. US8636671013 im Medizintechnik-Bereich, Illustration mit AI erstellt.

Needham reiterated its Buy rating and USD 418.00 price target for Stryker on October 6, 2026, according to Investing.com. Against the USD 295.97 NYSE price at 10:14 a.m. ET on October 16, 2026, that target was 41.23 percent higher. Stryker was trading at EUR 264.80 at 4:05 p.m. CEST at Lang & Schwarz on October 16, 2026, up 1.53 percent versus the Xetra close of October 15, 2026 at EUR 260.80.

Second-quarter revenue reached USD 6.59 billion

Stryker's second-quarter 2026 revenue was USD 6.59 billion, an increase of 9.40 percent from the year-earlier quarter, MarketBeat reported. Standardized financial data put second-quarter net income attributable to common shareholders at USD 1.276 billion and operating margin at 25.00 percent.

Stock sits 21.49 percent below its high

The euro quote stood within a 52-week range of EUR 210.60 to EUR 337.30 as of October 16, 2026. EUR 264.80 was 21.49 percent below the high and 25.71 percent above the low. The primary-market quote was USD 295.97, while the session volume was 367,501 shares against an average of 2,588,235 shares.

Valuation meets the October 29 date

Stryker's market capitalization was USD 113.5 billion and its price-to-earnings ratio was 30.84 as of October 16, 2026. StockTitan reported that Stryker will discuss third-quarter 2026 results on October 29, 2026, with the webcast scheduled for 4:30 p.m. ET.

Comparison with peers

Stryker Corporation: plus 1.53 percent, P/E 30.84, market capitalization USD 113.5 billion
Medtronic (NYSE, USD): minus 0.10 percent, P/E 23.57, market capitalization USD 122.0 billion
Edwards Lifesciences (NYSE, USD): minus 0.56 percent, P/E 50.49, market capitalization USD 50.5 billion

Price position for investors

StockAnalysis identifies Stryker Corporation as NYSE: SYK and assigns ISIN US8636671013, while the company's current market position combines a 30.84 price-to-earnings ratio with a 21.49 percent distance below the 52-week high. The stock was trading at EUR 264.80 at Lang & Schwarz on October 16, 2026 at 4:05 p.m. CEST, 1.53 percent above the Xetra close of October 15, 2026 at EUR 260.80. The further course of trading is shown by the continuously updated real-time quote of Stryker stock.